Of bugs and drugs. A guide through the labyrinth of antimicrobial therapy for respiratory tract infections.
Choosing appropriate antimicrobial therapy is no longer a simple process. Even for the common problems of respiratory tract disease in children and adults, selection is complicated by both increasing microbial resistance and the daunting number of extended-spectrum antibiotics now on the market. In this article, Drs Singh and Arrieta look at the problem from all aspects and give their specific recommendations.
Singh
J
J
Department of Pediatric Infectious Diseases, Children's Hospital of Orange County, California 92868, USA. jsingh@choc.org
Arrieta
A C
AC
D000208:Acute Disease; D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D004352:Drug Resistance, Microbial; D006801:Humans; D010033:Otitis Media / Q000188:drug therapy; D018410:Pneumonia, Bacterial / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D012852:Sinusitis / Q000188:drug therapy
D000900:Anti-Bacterial Agents